Dr Darrin M Disley Obe

Dr Darrin M Disley OBE is a prominent figure in biotechnology and investment, currently serving as a Non Executive Director at Roquefort Therapeutics plc, an Advisory Board Member at Sana Capital, and CEO of Mogrify, a company specializing in cell conversion technology. Dr Disley holds leadership roles including Chairman of the Board at Celixir, a regenerative medicine firm, and Principal & Founder of Carpe Diem Investment Fund, investing in IT, Tech, and Life Sciences. Previous contributions include roles as Chairman of Trustees at Footprint Cafes CIO, Honorary Visiting Fellow at The University of Salford, Honorary Fellow in Entrepreneurship at Cambridge Judge Business School, and Enterprise Fellow at the University of Cambridge. Dr Disley earned a PhD in Biotechnology from the University of Cambridge and holds a Doctor of Science (Honoris Causa) from The University of Salford.